Business
Why has the Kazia Therapeutics (ASX:KZA) share price skyrocketed 80% in 1 month?
The Kazia Therapeutics Ltd (ASX: KZA) share price is one of the best performers on the ASX this past month, almost doubling in value before retreating today by 12% to $1.53. Overall, the drugmaker’s share price has gained over 82% during the past month of trading.
Why the big rise in the Kazia share price
Kazia is a Sydney-based, oncology-focused biotechnology drugmaker. The company’s flagship is the paxalisib drug used for the treatment of glioblastoma, which is the most common and aggressive form of primary brain cancer. The Kazia share price has risen strongly on the back of the ongoing and promising development of this particular drug.
In August, paxalisib was granted a fast track designation (FTD) by the United…
-
General16 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News17 hours agoProtest calls for shark net removal
-
Noosa News19 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General22 hours agoVigils mark Israel attack anniversary, Gaza death toll